Cambridge Cognition

Cambridge Cognition is a software company providing digital cognitive assessment and clinical trial technology for central nervous system drug development.

Its validated computerised assessments measures cognitive function across memory, attention, and executive domains, with applications spanning Alzheimer's disease, schizophrenia, and other neurological conditions.

Additional products include an AI-driven quality assurance platform for CNS clinical scales, electronic clinical outcome assessments, and a decentralised clinical trial management platform. Through its Winterlight platform, the company is expanding into speech-based cognitive assessment for healthcare and consumer wellness markets, pursuing CE marking in Europe and FDA 510(k) clearance in the US.